All In Biotech

Drug Trial Radar · NCT02533973

Long-term Treatment of Scalp Psoriasis With Xamiol® Gel in a Large Adult Chinese Population

Last checked: Nov 19, 2026Latest source record: Feb 24, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 951 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

951

Actual

Start

Sep 2015

Primary completion

Mar 6, 2018

Study completion Mar 6, 2018

Sponsor

Lead sponsor
LEO PharmaIndustry
Sponsor type
Industry
Collaborators
Tigermed Consulting Co., Ltd
First posted
Aug 27, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Single (investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A phase 4 trial comparing the safety and efficacy of treatment with Xamiol® gel (calcipotriol 50 mcg/g plus betamethasone 0.5 mg/g (as dipropionate)) once daily (as required) with Daivonex® scalp solution (calcipotriol 50 mcg/g) twice daily (as required) in Chinese subjects with scalp psoriasis

Conditions

  • Psoriasis Vulgaris

Interventions

  • Xamiol® gelDrug

  • Daivonex® scalp solutionDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. safety of Xamiol® gel (adverse events)Time frame: 28 Weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • The Second Affiliated hospital Zhejiang University School of Medicine

    Hangzhou, Zhejiang, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.